Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3943955
Max Phase: Preclinical
Molecular Formula: C13H16O4S2
Molecular Weight: 300.40
Molecule Type: Small molecule
Associated Items:
ID: ALA3943955
Max Phase: Preclinical
Molecular Formula: C13H16O4S2
Molecular Weight: 300.40
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCc1ccc(C2=CS(=O)(=O)CCCS2(=O)=O)cc1
Standard InChI: InChI=1S/C13H16O4S2/c1-2-11-4-6-12(7-5-11)13-10-18(14,15)8-3-9-19(13,16)17/h4-7,10H,2-3,8-9H2,1H3
Standard InChI Key: UJIWLLJEAGNPFO-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 300.40 | Molecular Weight (Monoisotopic): 300.0490 | AlogP: 1.78 | #Rotatable Bonds: 2 |
Polar Surface Area: 68.28 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 0.58 | CX LogD: 0.58 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.83 | Np Likeness Score: -0.50 |
1. (2002) 1,4-dithiin and 1,4-dithiepin-1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor, |
Source(1):